Back to results
US 2026/0124258 A1Published application
Probiotic compositions for improving human health and athletic performance
AssigneeFitbiomics Inc.
InventorJonathan SCHEIMAN
Life of this patent
Estimating the term…
Abstract
The disclosure provides novel microorganisms, such as Lactobacillus sp., Bifidobacterium sp., and Veillonella sp., and compositions thereof for improving athletic performance, enhancing exercise endurance, improving physical recovery from exercise, and reducing inflammation in a subject in need thereof.
Claims40
A composition comprising one or more of the following strains:
- (a) an isolated and purified Lactobacillus plantarum, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of:
- VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 2;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 3;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 4;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 5;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 6;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 7;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 8;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 9;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 10;
- (b) an isolated and purified Lactobacillus rhamnosus, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 22;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 23;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 24;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 25;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 26;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 27;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 28;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 29;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 30;
- (c) an isolated and purified Lactobacillus acidophilus, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of:
- VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 42;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 43;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 44;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 45;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 46;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 47;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 48;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 49;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 50;
- (d) an isolated and purified Lactobacillus paracasei, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of:
- VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 62 or SEQ ID NO:
- 182;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 63 or SEQ ID NO:
- 183;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 64 or SEQ ID NO:
- 184;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 65 or SEQ ID NO:
- 185;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 66 or SEQ ID NO:
- 186;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 67 or SEQ ID NO:
- 187;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 68 or SEQ ID NO:
- 188;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 69 or SEQ ID NO:
- 189;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 70 or SEQ ID NO:
- 190;
- (e) an isolated and purified Bifidobacterium longum, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of:
- VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 82, SEQ ID NO:
- 202, or SEQ ID NO:
- 222;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 83, SEQ ID NO:
- 203, or SEQ ID NO:
- 223;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 84, SEQ ID NO:
- 204, or SEQ ID NO:
- 224;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 85, SEQ ID NO:
- 205, or SEQ ID NO:
- 225;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 86, SEQ ID NO:
- 206, or SEQ ID NO:
- 226;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 87, SEQ ID NO:
- 207, or SEQ ID NO:
- 227;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 88, SEQ ID NO:
- 208, or SEQ ID NO:
- 228;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 89, SEQ ID NO:
- 209, or SEQ ID NO:
- 229;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 90, SEQ ID NO:
- 210, or SEQ ID NO:
- 230;
- and
- (f) an isolated and purified Bifidobacterium animalis lactis, comprising:
- a 16S rRNA gene comprising a nucleic acid sequence comprising at least one variable region (VR) selected from the group consisting of:
- VR1, VR2, VR3, VR4, VR5, VR6, VR7, VR8, VR9, and any combination thereof, wherein (i) VR1 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 102;
- (ii) VR2 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 103;
- (iii) VR3 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 104;
- (iv) VR4 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 105;
- (v) VR5 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 106;
- (vi) VR6 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 107;
- (vii) VR7 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 108;
- (viii) VR8 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 109;
- and (ix) VR9 comprises a nucleic acid sequence with at least 95% sequence identity to SEQ ID NO:
- 110.
144 more elements
(canceled)
-9. (canceled)
-13. (canceled)
-17. (canceled)
-21. (canceled)
-32. (canceled)
A composition comprising:
- (a) a purified Lactobacillus plantarum comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 1;
- (b) a purified Lactobacillus rhamnosus comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 21;
- (c) a purified Lactobacillus acidophilus comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 41;
- (d) a purified Lactobacillus paracasei comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 61 or SEQ ID NO:
- 181;
- (e) a purified Bifidobacterium longum comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 81, SEQ ID NO:
- 201, or SEQ ID NO:
- 221;
- (f) a purified Bifidobacterium animalis lactis comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 101;
- (g) a purified Veillonella dispar comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 121;
- (h) a purified Veillonella parvula comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 141;
- and/or
- (i) a purified Veillonella atypica comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 161.
19 more elements
-35. (canceled)
-49. (canceled)
A composition comprising:
- (a) a purified Lactobacillus plantarum comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 1;
- (b) a purified Lactobacillus rhamnosus comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 21;
- and/or
- (c) a purified Lactobacillus acidophilus comprising a 16S rRNA nucleic acid sequence that is at least 97% identical to SEQ ID NO:
- 41.
4 more elements
Dependencies are inferred from the claim text.